GSK RSV Vaccine Phase III Trials Show Positive Preliminary Results, Expanding Eligibility to the 50-59 Age Group! GSK RSV Vaccine...
GSK
Vaccine giant starts patent war: GSK sues Pfizer for RSV vaccine patent infringement. British vaccine manufacturer GlaxoSmithKline (GSK) formally sued...
Pfizer and GlaxoSmithKline RSV Vaccine Receives Limited Support from US CDC Experts Pfizer and GlaxoSmithKline RSV Vaccine Receives Limited...
First RSV vaccine: Pfizer and GSK have successively passed FDA committee review First RSV vaccine: Pfizer and GSK have...
